Reply to Ghosh et al ¹ . Comments on Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder

Ateeq Ahmad,Saifuddin Sheikh,Mujtaba Ali Khan, Alok Chaturvedi,Piyush Patel,Ronak Patel,Bakul Chandrakant Buch,Rajendra Someshwar Anand,Timirkumar Chandrakant Shah,Vaishal Nareshchandra Vora, Vikhram Ramasubramanian,Satyanarayana Rao, Narendra Kumar, B. S. V. Prasad,Ramanathan Sathianathan,Kamal Kumar Verma,Venu Gopal Jhanwar,Nand Kumar, Sandip Shah,Pronob Kumar Dalal,Brahmdeep Sindhu,Payel Talukdar,Imran Ahmad

Bipolar Disorders（2021）

引用 0|浏览3

暂无评分

摘要

We reviewed Ghosh et al. letter based on our active-controlled, double-blind, and randomized trial that demonstrated the therapeutic benefit of Endoxifen in patients with bipolar I disorder.

查看译文

关键词

mixed mania,endoxifen,protein kinase,inhibitor

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要

Reply to Ghosh et al 1 . Comments on Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder

Reply to Ghosh et al ¹ . Comments on Endoxifen: A new, protein kinase C inhibitor to treat acute and mixed mania associated with bipolar I disorder